2-3 February, 2022  |  Online Conference
This virtual conference was jointly organised by GARDP and the BSAC. This conference is RCPath CPD accredited.
For 2022, we collaborated with the Center For Disease Dynamics, Economics & Policy (CDDEP) and the Indian Council of Medical Research (ICMR).

Programme

Recorded content from this conference can be viewed below.

SESSION ONE: KEYNOTE PRESENTATION

View session one. This video consists of the following presentations:

Watch Presentation

Introductory remarks

Professor Laura JV Piddock, Scientific Director, GARDP - View Bio

Regulatory challenges and global access to new antibiotics

Dr Ramanan Laxminarayan, Director, CDDEP - View Bio

SESSION TWO: Early drug discovery: new targets and new chemistry

View session two. This video consists of the following presentations:

Watch Presentation

Dual fluorescent timer module for screening of anti-persister agents

Professor Ranjana Pathania, Professor Indian Institute of Technology Roorkee (IIT Roorkee) - View Bio

Discovery and optimization of β-sliding clamp (DnaN) inhibitors

Professor Dr Anna Hirsch, Head of department, Drug Design and Optimization (DDOP) Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS) - View Bio

New ways to identify novel antibacterial chemical entities - Identification of Novel Antibacterials Using Machine Learning Techniques

Mr Ed Siegwart, Director of Microbiology, Oppilotech Ltd - View Bio

Q&A

SESSION THREE: Preclinical antimicrobial development

View session three. This video consists of the following presentations:

Watch Presentation

WHO Priority pathogen list and WHO preclinical pipeline analysis

Dr Valeria Gigante, Team Lead, One Health Research Priority-setting and Synergy in AMR, WHO - View Bio

Overview of CARB-X pipeline

Dr Erin Duffy, Chief of Research & Development, CARB-X - View Bio

SESSION FOUR: Panel Discussion

View session four. This video consists of the following presentations:

Watch Presentation

Panellist

Dr Susan Hopkins - View Bio

Panellist

Dr Priscilla Rupali - View Bio

Panellist

Dr Subasree Srinivasan - View Bio

Panellist

Prof. Dr Evelina Tacconelli - View Bio

Day one closing remarks

Dr Christopher Longshaw, Senior Director, EU Scientific Affairs, Shionogi BV & BSAC Honorary Treasurer - View Bio

SESSION FIVE: Clinical development

View session five. This video consists of the following presentations:

Watch Presentation

Introductory remarks

Dr Christopher Longshaw, EU Scientific Advisor, Shionogi & BSAC Honorary Treasurer - View Bio

Overview of clinical pipeline for antimicrobials - will it meet the future unmet need?

Professor Mical Paul, Head, Division of Infectious Diseases, Rambam Health Care Campus, Israel - View Bio

Emerging antibiotic market in the Indian subcontinent

Mr Anmol Aggarwal, Lead, R&D Strategy, Venus Medicine Research Centre, India - View Bio

Clinical development of non-traditional antibiotics

Dr Balganesh Tanjore Soundararajan, President, Gangagen Biotechnologies Pvt Ltd, Bangalore, India - View Bio

Q&A

SESSION SIX: Oral Poster Presentations

View session six. This video consists of the following presentations:

Watch Presentation

Evaluating the veterinarian role in one health approach at antimicrobial resistance perspectives, Jordan

Bazzi Randa, Faculty of Public Health, University of Debrecen - View Bio

The ESKAPE pathogens mobilome

João Botelho, Postdoctoral Researcher, Max Planck Institute for Evolutionary Biology - View Bio

Utilising health belief model to assess antimicrobial awareness of Western Australian parents: A qualitative study

Aaron Alejandro, PhD Candidate, Murdoch University Australia - View Bio

Nanobodies as inhibitors of the SOS-response: a new class of potential suppressors of antimicrobial resistance

Filippo Vascon, PhD student, Università degli Studi di Padova - View Bio

Phage mediated beta-lactamases and carbapenemases in multi-drug resistant Escherichia coli

Juliet Roshini Mohan Raj, Assistant Professor, Nitte University Centre for Science Education and Research - View Bio

Q&A

SESSION SEVEN: Impact of the COVID-19 pandemic on infections and antimicrobial resistance

View session seven. This video consists of the following presentations:

Watch Presentation

Impact of Covid 19 on Antimicrobial stewardship

Dr Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde - View Bio

How has Indian AMR data changed post-Covid

Dr Kamini Walia, Program officer AMR Division of Epidemiology and Communicable Diseases, Indian Council of Medical Research - View Bio

Impact of Covid-19 on treatment of fungal infections

Dr Arunaloke Chakrabarti, President of International Society for Human and Animal Mycology (ISHAM) - View Bio

Q&A

SESSION EIGHT: Panel Discussion - More than one way to do it – R&D of new antimicrobials: incentives and models

View session eight. This video consists of the following presentations:

Watch Presentation

Panellist

Dr Anand Anandkumar, Dr Jean-Pierre Paccaud, Ms Jenny Hellmann - View Bio

Panellist

Dr Anand Anandkumar, Co-Founder & CEO of Bugworks - View Bio

Panellist

Dr Jean-Pierre Paccaud, Director, Business Development and Corporate Strategy Global Antibiotic R&D Partnership (GARDP) - View Bio

Panellist

Ms Jenny Hellmann, Assistant chief of Antibiotics and Infection control unit, Public Health Agency of Sweden - View Bio

Closing remarks

Professor Laura JV Piddock, Scientific Director, GARDP - View Bio

Virtual poster gallery

Click here to view the virtual poster gallery from the conference